Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Shiba Inu Coin Could Bounce Back, If Crypto Comes Back in Vogue

Other factors may point to further losses, or perhaps just middling performance for cryptocurrencies. Yet if you want to take a gamble this asset class recovers? There's no harm making a high-risk, but possibly high-return wager on Shiba Inu.

Meta Materials Has Room to Fall Before it Hits a Reasonable Price

Buying MMAT stock today makes little sense if you’re buying based on its fundamentals. But that's not how some investors approach it.

Palantir Remains a Wonderful Company at an Inflated Price

The big data company's advantages may help it hold steady, but barring another meme stock wave, don't count on another boost for PLTR stock.

Buy ContextLogic Stock Now, Ahead of Its Likely Comeback

This week's results may not suddenly change the sentiment around WISH stock. Yet in time, the negativity weighing it down today will dissipate.

Fast Growth and a Rich Valuation Could Keep DraftKings Stock Steady

DKNG stock is in a quickly growing industry, but concerns about competition and profitability could keep it from moving much higher.

Despite Novavax’s Challenges, NVAX Stock Could Still Pop

NVAX stock could drop on further disappointment. But it's poised to rally big if its Covid-19 vaccine beats expectations.

Possible Regulatory Changes Could Threaten an Ethereum Comeback

The "upgrades fueling a further rebound" thesis still has a shot of playing out. But for now, it may be best to wait for markets to absorb the specter of increased regulatory compliance before buying Ethereum.

Fading Hype and Too Many Unknowns Signal To Steer Clear of Vinco Ventures

BBIG stock's not getting much attention now on r/WallStreetBets. The lack of details with a recent deal signal it's not best to gamble on this situation.

7 SPACs With The Most Potential as Scrutiny of Blank-Check Firms Grows

Separating good opportunities from the bad ones, which SPACs stand out as name with the most room to gain in the coming years? Consider these seven solid contenders to deliver strong long-term returns for investors.

7 Reddit Stocks To Buy if The ‘Meme Stocks’ Trend Has Runway

If the "meme stocks" trend is here to stay, names popular with the r/WallStreetBets community could change over time. These seven Reddit stocks could have the potential to rebound to their prior highs in the coming months.